| Wirth Chiropractic | |
|
2100 W Arlington Blvd, Greenville, NC 27834-6487 | |
| (252) 756-6111 | |
| Not Available |
| Full Name | Wirth Chiropractic |
|---|---|
| Type | Facility |
| Speciality | Chiropractor |
| Location | 2100 W Arlington Blvd, Greenville, North Carolina |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114663424 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 111N00000X | Chiropractor | (* (Not Available)) | Primary |
| Provider Name | Brian J Wirth |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1396077087 PECOS PAC ID: 3678602380 Enrollment ID: I20100518000670 |
News Archive
Kaiser Health News reports on Alaska's Southcentral Foundation.
Research has shown that New Year's is the deadliest day of the year for pedestrians. Drinking and walking can be as dangerous as drinking and driving. Trauma surgeon Dr. Thomas Esposito has seen the tragic effects of drunk walking, among his patients and in his own family.
Serious mental illness such as depression, bipolar disorder, and schizophrenia has been shown to affect relationships and parenting capabilities.
Actavis plc today announced that the Anti-Infective Drugs Advisory Committee convened by the U.S. Food and Drug Administration has voted to recommend approval of Actavis' New Drug Application (NDA) for ceftazidime-avibactam, an investigational antibiotic being developed to treat hospitalized patients when limited or no treatment options are available for complicated intra-abdominal infections (cIAI) (in combination with metronidazole) and complicated urinary tract infections (cUTI) (including acute pyelonephritis) caused by Gram-negative pathogens.
Cellectricon, a leading provider of advanced cell-based screening technologies and services, will co-host a webinar with top researchers at University College London. The webinar will explore the use of primary cells as a biologically-relevant model for biomedical research, and highlight the new high-throughput techniques and phenotypic screening approaches that are used by UCL to investigate cellular processes in such cells.
› Verified 7 days ago
| Provider Name | Jeremy D Cannon |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1467824953 PECOS PAC ID: 8527363696 Enrollment ID: I20180409002092 |
News Archive
Kaiser Health News reports on Alaska's Southcentral Foundation.
Research has shown that New Year's is the deadliest day of the year for pedestrians. Drinking and walking can be as dangerous as drinking and driving. Trauma surgeon Dr. Thomas Esposito has seen the tragic effects of drunk walking, among his patients and in his own family.
Serious mental illness such as depression, bipolar disorder, and schizophrenia has been shown to affect relationships and parenting capabilities.
Actavis plc today announced that the Anti-Infective Drugs Advisory Committee convened by the U.S. Food and Drug Administration has voted to recommend approval of Actavis' New Drug Application (NDA) for ceftazidime-avibactam, an investigational antibiotic being developed to treat hospitalized patients when limited or no treatment options are available for complicated intra-abdominal infections (cIAI) (in combination with metronidazole) and complicated urinary tract infections (cUTI) (including acute pyelonephritis) caused by Gram-negative pathogens.
Cellectricon, a leading provider of advanced cell-based screening technologies and services, will co-host a webinar with top researchers at University College London. The webinar will explore the use of primary cells as a biologically-relevant model for biomedical research, and highlight the new high-throughput techniques and phenotypic screening approaches that are used by UCL to investigate cellular processes in such cells.
› Verified 7 days ago
| Provider Name | Mark Saletnik |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1356617963 PECOS PAC ID: 6507765492 Enrollment ID: I20191126001141 |
News Archive
Kaiser Health News reports on Alaska's Southcentral Foundation.
Research has shown that New Year's is the deadliest day of the year for pedestrians. Drinking and walking can be as dangerous as drinking and driving. Trauma surgeon Dr. Thomas Esposito has seen the tragic effects of drunk walking, among his patients and in his own family.
Serious mental illness such as depression, bipolar disorder, and schizophrenia has been shown to affect relationships and parenting capabilities.
Actavis plc today announced that the Anti-Infective Drugs Advisory Committee convened by the U.S. Food and Drug Administration has voted to recommend approval of Actavis' New Drug Application (NDA) for ceftazidime-avibactam, an investigational antibiotic being developed to treat hospitalized patients when limited or no treatment options are available for complicated intra-abdominal infections (cIAI) (in combination with metronidazole) and complicated urinary tract infections (cUTI) (including acute pyelonephritis) caused by Gram-negative pathogens.
Cellectricon, a leading provider of advanced cell-based screening technologies and services, will co-host a webinar with top researchers at University College London. The webinar will explore the use of primary cells as a biologically-relevant model for biomedical research, and highlight the new high-throughput techniques and phenotypic screening approaches that are used by UCL to investigate cellular processes in such cells.
› Verified 7 days ago
| Provider Name | Samantha Davenport O'kane |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1316586449 PECOS PAC ID: 2163858879 Enrollment ID: I20200128002125 |
News Archive
Kaiser Health News reports on Alaska's Southcentral Foundation.
Research has shown that New Year's is the deadliest day of the year for pedestrians. Drinking and walking can be as dangerous as drinking and driving. Trauma surgeon Dr. Thomas Esposito has seen the tragic effects of drunk walking, among his patients and in his own family.
Serious mental illness such as depression, bipolar disorder, and schizophrenia has been shown to affect relationships and parenting capabilities.
Actavis plc today announced that the Anti-Infective Drugs Advisory Committee convened by the U.S. Food and Drug Administration has voted to recommend approval of Actavis' New Drug Application (NDA) for ceftazidime-avibactam, an investigational antibiotic being developed to treat hospitalized patients when limited or no treatment options are available for complicated intra-abdominal infections (cIAI) (in combination with metronidazole) and complicated urinary tract infections (cUTI) (including acute pyelonephritis) caused by Gram-negative pathogens.
Cellectricon, a leading provider of advanced cell-based screening technologies and services, will co-host a webinar with top researchers at University College London. The webinar will explore the use of primary cells as a biologically-relevant model for biomedical research, and highlight the new high-throughput techniques and phenotypic screening approaches that are used by UCL to investigate cellular processes in such cells.
› Verified 7 days ago
| Provider Name | Brett A Okane |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1861031999 PECOS PAC ID: 3274969688 Enrollment ID: I20200204000019 |
News Archive
Kaiser Health News reports on Alaska's Southcentral Foundation.
Research has shown that New Year's is the deadliest day of the year for pedestrians. Drinking and walking can be as dangerous as drinking and driving. Trauma surgeon Dr. Thomas Esposito has seen the tragic effects of drunk walking, among his patients and in his own family.
Serious mental illness such as depression, bipolar disorder, and schizophrenia has been shown to affect relationships and parenting capabilities.
Actavis plc today announced that the Anti-Infective Drugs Advisory Committee convened by the U.S. Food and Drug Administration has voted to recommend approval of Actavis' New Drug Application (NDA) for ceftazidime-avibactam, an investigational antibiotic being developed to treat hospitalized patients when limited or no treatment options are available for complicated intra-abdominal infections (cIAI) (in combination with metronidazole) and complicated urinary tract infections (cUTI) (including acute pyelonephritis) caused by Gram-negative pathogens.
Cellectricon, a leading provider of advanced cell-based screening technologies and services, will co-host a webinar with top researchers at University College London. The webinar will explore the use of primary cells as a biologically-relevant model for biomedical research, and highlight the new high-throughput techniques and phenotypic screening approaches that are used by UCL to investigate cellular processes in such cells.
› Verified 7 days ago
| Provider Name | Hannah E Bressler |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1053928283 PECOS PAC ID: 3072927409 Enrollment ID: I20211228000407 |
News Archive
Kaiser Health News reports on Alaska's Southcentral Foundation.
Research has shown that New Year's is the deadliest day of the year for pedestrians. Drinking and walking can be as dangerous as drinking and driving. Trauma surgeon Dr. Thomas Esposito has seen the tragic effects of drunk walking, among his patients and in his own family.
Serious mental illness such as depression, bipolar disorder, and schizophrenia has been shown to affect relationships and parenting capabilities.
Actavis plc today announced that the Anti-Infective Drugs Advisory Committee convened by the U.S. Food and Drug Administration has voted to recommend approval of Actavis' New Drug Application (NDA) for ceftazidime-avibactam, an investigational antibiotic being developed to treat hospitalized patients when limited or no treatment options are available for complicated intra-abdominal infections (cIAI) (in combination with metronidazole) and complicated urinary tract infections (cUTI) (including acute pyelonephritis) caused by Gram-negative pathogens.
Cellectricon, a leading provider of advanced cell-based screening technologies and services, will co-host a webinar with top researchers at University College London. The webinar will explore the use of primary cells as a biologically-relevant model for biomedical research, and highlight the new high-throughput techniques and phenotypic screening approaches that are used by UCL to investigate cellular processes in such cells.
› Verified 7 days ago
| Provider Name | Daniel Peter Hartwell |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1831885078 PECOS PAC ID: 0143685164 Enrollment ID: I20230426003226 |
News Archive
Kaiser Health News reports on Alaska's Southcentral Foundation.
Research has shown that New Year's is the deadliest day of the year for pedestrians. Drinking and walking can be as dangerous as drinking and driving. Trauma surgeon Dr. Thomas Esposito has seen the tragic effects of drunk walking, among his patients and in his own family.
Serious mental illness such as depression, bipolar disorder, and schizophrenia has been shown to affect relationships and parenting capabilities.
Actavis plc today announced that the Anti-Infective Drugs Advisory Committee convened by the U.S. Food and Drug Administration has voted to recommend approval of Actavis' New Drug Application (NDA) for ceftazidime-avibactam, an investigational antibiotic being developed to treat hospitalized patients when limited or no treatment options are available for complicated intra-abdominal infections (cIAI) (in combination with metronidazole) and complicated urinary tract infections (cUTI) (including acute pyelonephritis) caused by Gram-negative pathogens.
Cellectricon, a leading provider of advanced cell-based screening technologies and services, will co-host a webinar with top researchers at University College London. The webinar will explore the use of primary cells as a biologically-relevant model for biomedical research, and highlight the new high-throughput techniques and phenotypic screening approaches that are used by UCL to investigate cellular processes in such cells.
› Verified 7 days ago
| Provider Name | David A Caldwell |
|---|---|
| Provider Type | Practitioner - Chiropractic |
| Provider Identifiers | NPI Number: 1962841643 PECOS PAC ID: 0749528545 Enrollment ID: I20230725003467 |
News Archive
Kaiser Health News reports on Alaska's Southcentral Foundation.
Research has shown that New Year's is the deadliest day of the year for pedestrians. Drinking and walking can be as dangerous as drinking and driving. Trauma surgeon Dr. Thomas Esposito has seen the tragic effects of drunk walking, among his patients and in his own family.
Serious mental illness such as depression, bipolar disorder, and schizophrenia has been shown to affect relationships and parenting capabilities.
Actavis plc today announced that the Anti-Infective Drugs Advisory Committee convened by the U.S. Food and Drug Administration has voted to recommend approval of Actavis' New Drug Application (NDA) for ceftazidime-avibactam, an investigational antibiotic being developed to treat hospitalized patients when limited or no treatment options are available for complicated intra-abdominal infections (cIAI) (in combination with metronidazole) and complicated urinary tract infections (cUTI) (including acute pyelonephritis) caused by Gram-negative pathogens.
Cellectricon, a leading provider of advanced cell-based screening technologies and services, will co-host a webinar with top researchers at University College London. The webinar will explore the use of primary cells as a biologically-relevant model for biomedical research, and highlight the new high-throughput techniques and phenotypic screening approaches that are used by UCL to investigate cellular processes in such cells.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Wirth Chiropractic 2100 W Arlington Blvd, Greenville, NC 27834 Ph: (252) 999-9371 | Wirth Chiropractic 2100 W Arlington Blvd, Greenville, NC 27834-6487 Ph: (252) 756-6111 |
News Archive
Kaiser Health News reports on Alaska's Southcentral Foundation.
Research has shown that New Year's is the deadliest day of the year for pedestrians. Drinking and walking can be as dangerous as drinking and driving. Trauma surgeon Dr. Thomas Esposito has seen the tragic effects of drunk walking, among his patients and in his own family.
Serious mental illness such as depression, bipolar disorder, and schizophrenia has been shown to affect relationships and parenting capabilities.
Actavis plc today announced that the Anti-Infective Drugs Advisory Committee convened by the U.S. Food and Drug Administration has voted to recommend approval of Actavis' New Drug Application (NDA) for ceftazidime-avibactam, an investigational antibiotic being developed to treat hospitalized patients when limited or no treatment options are available for complicated intra-abdominal infections (cIAI) (in combination with metronidazole) and complicated urinary tract infections (cUTI) (including acute pyelonephritis) caused by Gram-negative pathogens.
Cellectricon, a leading provider of advanced cell-based screening technologies and services, will co-host a webinar with top researchers at University College London. The webinar will explore the use of primary cells as a biologically-relevant model for biomedical research, and highlight the new high-throughput techniques and phenotypic screening approaches that are used by UCL to investigate cellular processes in such cells.
› Verified 7 days ago
Dr. Brian M Kean, D.C. Chiropractor Medicare: Medicare Enrolled Practice Location: 504 Red Banks Rd # C, Greenville, NC 27858 Phone: 252-321-3579 | |
Dr. Bruce D Mccrea, D.C., FNP Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 216 E Arlington Blvd, Greenville, NC 27858 Phone: 252-757-0004 Fax: 252-757-0095 | |
Dr. Robert F Mccarthy, D. C. Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 916 Evans St, Greenville, NC 27834 Phone: 252-758-2222 Fax: 252-758-2524 | |
Forsyth Chiropractic And Wellness Llc Chiropractor Medicare: Medicare Enrolled Practice Location: 1330 E Arlington Blvd Ste B, Greenville, NC 27858 Phone: 252-355-5353 | |
Ryan Mcgloon, D.C Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 504 Red Banks Rd Ste C, Greenville, NC 27858 Phone: 252-321-3579 Fax: 252-321-3576 | |
Healthcare Chiropractic Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 1429 E Fire Tower Rd, Ste 104, Greenville, NC 27858 Phone: 252-758-2477 Fax: 252-758-8477 |